|Articles|June 1, 1999

Clinical and Economic Opportunities of Anti-TNF Therapies in Rheumatoid Arthritis
Volume 5
Issue 8 Suppl

Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritis

Author(s)Arthur Kavanaugh, MD

Download PDF: Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritis

Articles in this issue

about 27 years ago

Article

Participating Faculty

about 27 years ago

Article

Introduction

about 27 years ago

Article

Methotrexate Therapy in the Year 2000: Outstanding Questions

about 27 years ago

Article

State-of-the-Art Combination Therapy in 1999

about 27 years ago

Article

Assessing New Therapies for RA: Defining New Expectations for Treatment; New Therapies in Clinical Practice: Issues of Cost and Access

about 27 years ago

Article

The Emerging Role of Anti-TNF Therapy in the Treatment of Rheumatoid Arthritis

about 27 years ago

Article

Selected Abstracts

about 27 years ago

Article

CME Quiz

about 27 years ago

Article

Bibliography

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

June 4th 2026

Orthopedic surgeon holds bone x-ray | Image Credit: © tippapatt - stock.adobe.com

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

ByHannah I. Travers, MD,Mikhail Kuznetsov, MD,John Mazzocco, MD,Nicholas Pagani, MD,Tricia Ide, DNP, RN,Brian L. Hollenbeck, MD,Eric L. Smith, MD

June 3rd 2026

Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritis

Articles in this issue

Related Content

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

Trending on AJMC

Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata

Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story

First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA

Endometriosis Reduces Ovarian Reserve via Inflammation and Surgery

From EASL 2026: What Hepatology Still Needs to Solve